RecruitingNot Applicable

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

Italy6,000 participantsStarted 2020-03-19

Plain-language summary

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients admitted to hospital with biological samples positive for SARS-CoV-2 * Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease * Patients discharged from emergency department with biological samples positive for SARS-CoV-2 Exclusion Criteria: * None

What they're measuring

Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Timeframe: Hospital stay (2-3 weeks)

Trial details

NCT IDNCT04318366

SponsorUniversità Vita-Salute San Raffaele

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06-19

Contact for this trial

Giovanni Landoni, Professor

+390226436151 landoni.giovanni@hsr.it

View on ClinicalTrials.gov More Coronavirus Infections trials